Lee Kang Min, Joung Hannah, Heo Jung Won, Woo Seo Kyung, Woo In Sook, Jung Yun Hwa
Division of Medical Oncology, Department of Internal Medicine, Yeouido St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, South Korea.
Case Rep Oncol. 2016 Jun 14;9(2):321-7. doi: 10.1159/000446911. eCollection 2016 May-Aug.
Hepatic infarction is known as a rare disease entity in nontransplant patients. Although a few cases of hepatic infarction have been reported to be linked with invasive procedures, trauma, and hypercoagulability, a case of spontaneous hepatic infarction in a nontransplanted patient has hardly ever been reported. However, many clinical situations of patients with cancer, in particular biliary cancer, can predispose nontransplant patients to hepatic infarction. Besides, the clinical outcome of hepatic infarction in patients with cancer can be worse than in patients with other etiologies. As for treatment, anticoagulation treatment is usually recommended. However, because of its multifactorial etiology and combined complications, treatment of hepatic infarction is difficult and not simple. Herein, we report a case of fatal hepatic infarction that occurred spontaneously during the course of treatment in a patient with gallbladder cancer. Hepatic infarction should be considered as a possible fatal complication in patients during treatment of biliary malignancies.
肝梗死在非移植患者中是一种罕见的疾病实体。尽管有少数肝梗死病例据报道与侵入性操作、创伤和高凝状态有关,但非移植患者自发性肝梗死的病例几乎从未被报道过。然而,许多癌症患者,尤其是胆管癌患者的临床情况,可使非移植患者易患肝梗死。此外,癌症患者肝梗死的临床结局可能比其他病因患者更差。至于治疗,通常推荐抗凝治疗。然而,由于其病因多因素且合并并发症,肝梗死的治疗困难且不简单。在此,我们报告一例胆囊癌患者在治疗过程中发生的致命性自发性肝梗死病例。在胆管恶性肿瘤患者的治疗过程中,应将肝梗死视为一种可能的致命并发症。